Cassava Sciences Inc.

285 articles about Cassava Sciences Inc.

• Pain Therapeutics Announces Second Quarter 2007 Financial Results

  8/9/2007

• Pain Therapeutics to Present At the Goldman, Sachs & Co. Healthcare Conference

  6/6/2007

• Pain Therapeutics to Present at Two Upcoming Investor Conferences

  5/22/2007

• Pain Therapeutics Announces First Quarter 2007 Financial Results

  5/2/2007

• Pain Therapeutics Announces $20 Million Stock Buyback Plan

  3/29/2007

• The Day In Review: Eisai Inc. Buys Morphotek Inc. For $325 Million

  3/22/2007

• Pain Therapeutics Licenses Biotechnology To Treat Rare Disorder

  3/22/2007

• Pain Therapeutics Cleared to Initiate Phase I Study in Metastatic Melanoma

  3/20/2007

• Chromos Molecular Systems Inc. And Pain Therapeutics Sign Cell Line Engineering Agreement

  3/20/2007

• Pain Therapeutics to Participate at Oppenheimer's Pain Management Conference

  2/27/2007

• Pain Therapeutics Announces Fourth Quarter And Year-End 2006 Financial Results

  2/5/2007

• Pain Therapeutics Initiates Phase III Study With Oxytrex(TM)

  12/13/2006

• Pain Therapeutics Announces Positive Phase I Study Results With PTI-202

  11/29/2006

• Pain Therapeutics Announces New Clinical Opportunity In Metastatic Melanoma

  11/9/2006

• Pain Therapeutics Announces Third Quarter 2006 Financial Results

  10/25/2006

• Pain Therapeutics Release: Oxytrex(TM) Mechanism Of Action Further Elucidated

  10/17/2006

• Pain Therapeutics To Present At The UBS Warburg Global Life Sciences Conference

  9/20/2006

• Pain Therapeutics Announces Second Quarter 2006 Financial Results

  8/9/2006

• The Day In Review: Pozen, Inc. Inks Pain Deal With AstraZeneca PLC

  8/2/2006

• Pain Therapeutics And King Pharmaceuticals®, Inc. Initiate Clinical Program Of A Second Abuse-Resistant Painkiller; Triggers $5 Million Milestone Payment

  8/2/2006